loading
전일 마감가:
$4.35
열려 있는:
$4.39
하루 거래량:
239.62K
Relative Volume:
0.17
시가총액:
$91.59M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+77.07%
1개월 성능:
+423.33%
6개월 성능:
+309.57%
1년 성능:
+0.00%
1일 변동 폭
Value
$4.25
$4.97
1주일 범위
Value
$2.43
$6.19
52주 변동 폭
Value
$0.5506
$6.19

Citius Oncology Inc Stock (CTOR) Company Profile

Name
명칭
Citius Oncology Inc
Name
전화
(908) 967-6677
Name
주소
11 COMMERCE DRIVE, CRANFORD
Name
직원
0
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
CTOR's Discussions on Twitter

CTOR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
CTOR
Citius Oncology Inc
4.71 91.59M 0 0 0 0.00
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
16.00 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
155.29 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.34 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.45 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.64 20.17B 16.54B -1.64B 749.00M -1.45

Citius Oncology Inc Stock (CTOR) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-11-27 개시 Maxim Group Buy

Citius Oncology Inc 주식(CTOR)의 최신 뉴스

pulisher
Jun 17, 2025

Citius Oncology prepares for lymphoma treatment launch in 2025 By Investing.com - Investing.com Nigeria

Jun 17, 2025
pulisher
Jun 17, 2025

Citius Oncology On Track to Launch Lymphir in US in H2 - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Citius Oncology prepares for lymphoma treatment launch in 2025 - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025 - StreetInsider

Jun 17, 2025
pulisher
Jun 13, 2025

Citius Oncology enters distribution services agreement with Cardinal Health - MSN

Jun 13, 2025
pulisher
Jun 13, 2025

Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - The Victoria Advocate

Jun 13, 2025
pulisher
Jun 13, 2025

Citadel Advisors LLC Makes New $26,000 Investment in Citius Oncology, Inc. (NASDAQ:CTOR) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

After Major Oncology Conference, All Eyes Turn to Industry Innovation - Cantech Letter

Jun 12, 2025
pulisher
Jun 12, 2025

Citius Pharmaceuticals Announces a Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - Longview News-Journal

Jun 12, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals Secures $15.8M Strategic Financing: LYMPHIR Commercial Launch Gets Green Light - Stock Titan

Jun 10, 2025
pulisher
Jun 09, 2025

Citius Oncology partners with Cardinal Health for LYMPHIR distribution By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology Enters Into Distribution Services Agreement With Cardinal Health - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology Signs US Distribution Deal With Cardinal Health for Lymphir - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

Cardinal Health (CAH) Partners with Citius Oncology for LYMPHIR Distribution | CAH Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology Inks Distribution Services Agreement With Cardinal Health For LYMPHIR - Nasdaq

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology stock soars on distribution deal By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology stock soars on distribution deal - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology partners with Cardinal Health for LYMPHIR distribution - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology Enters into Distribution Services Agreement with Cardinal Health | CTXR Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology Enters into Distribution Services Agreement with Cardinal Health - Yahoo Finance

Jun 09, 2025
pulisher
Jun 06, 2025

Citius Oncology (NASDAQ:CTOR) Trading Up 3.4% – Here’s Why - Defense World

Jun 06, 2025
pulisher
May 23, 2025

This Deckers Outdoor Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga

May 23, 2025
pulisher
May 23, 2025

Maxim Downgrades Citius Oncology to Hold From Buy - marketscreener.com

May 23, 2025
pulisher
May 14, 2025

Citius Oncology (CTXR) Seeks Additional Capital for LYMPHIR Laun - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Citius Oncology (CTXR) Seeks Additional Capital for LYMPHIR Launch | CTXR Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results And Provides Business Update - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update - PR Newswire

May 14, 2025
pulisher
May 14, 2025

Citius Pharmaceuticals Reports Critical Cash Position, Advances FDA-Approved LYMPHIR Launch Strategy - Stock Titan

May 14, 2025
pulisher
May 07, 2025

Citius Oncology, Inc. (NASDAQ:CTOR) Is Expected To Breakeven In The Near Future - Yahoo Finance

May 07, 2025
pulisher
May 05, 2025

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference | CTXR Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - PR Newswire

May 05, 2025
pulisher
May 05, 2025

Citius Pharmaceuticals to Present at the Jefferies Global Health - GuruFocus

May 05, 2025
pulisher
Apr 26, 2025

US Stocks Dip As Investors Eye Trump's Tariff Announcements - Finimize

Apr 26, 2025
pulisher
Apr 25, 2025

Citius Oncology IncReceives Nasdaq Notice For Bid Price Non-ComplianceSEC Filing - marketscreener.com

Apr 25, 2025
pulisher
Apr 23, 2025

Citius Oncology (NASDAQ:CTOR) Trading 6.3% Higher – Still a Buy? - Defense World

Apr 23, 2025
pulisher
Apr 04, 2025

Citius Pharmaceuticals Announces $2 Million Registered Direct Offering of Common Stock - Longview News-Journal

Apr 04, 2025
pulisher
Apr 02, 2025

Citius Oncology Inc (NASDAQ: CTOR) Is On The Fall - stocksregister.com

Apr 02, 2025
pulisher
Apr 01, 2025

Citius Pharma secures $2 million in stock offering By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Citius Pharma secures $2 million in stock offering - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

Citius Oncology (NASDAQ:CTOR) Shares Up 39.8% – Still a Buy? - Defense World

Apr 01, 2025
pulisher
Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

3 Penny Stocks to Watch Now, 4/1/25 - TipRanks

Apr 01, 2025
pulisher
Mar 31, 2025

Why Citius Oncology Inc. Stock Spiked Over 7%? - timothysykes.com

Mar 31, 2025
pulisher
Mar 31, 2025

Why Xos Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 31, 2025
pulisher
Mar 24, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Mar 24, 2025

Citius Oncology Inc (CTOR) 재무 분석

Citius Oncology Inc (CTOR)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$14.24
price down icon 0.28%
$8.935
price up icon 0.00%
$127.85
price up icon 1.82%
$288.42
price up icon 0.48%
drug_manufacturers_specialty_generic RDY
$14.95
price down icon 0.57%
$16.64
price down icon 0.58%
자본화:     |  볼륨(24시간):